GNH USA

Europe — EMA

Olmesartán/Amlodipino Stada (Olmesartan Medoxomil, Amlodipine)

GNH USA supplies Olmesartán/Amlodipino Stada (Olmesartan), an ARB for hypertension and cardiovascular risk management. Request a quote for global supply.

Olmesartan Medoxomil, Amlodipine

Request sourcing

1
Pack/s

What is Olmesartan Medoxomil, Amlodipine?

Olmesartan medoxil, the active ingredient in Olmesartán/Amlodipino Stada, is an angiotensin II receptor blocker (ARB) presented as a oral tablet for systemic use. It treats hypertension and may be used in adults requiring blood pressure control.

GNH USA supplies Olmesartán/Amlodipino Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Olmesartan Medoxomil, Amlodipine used for?

Olmesartan medoxil combined with amlodipine is indicated for hypertension management, targeting the renin‑angiotensin system and calcium‑channel pathways. - Hypertension: improves blood pressure control when monotherapy is insufficient. - High‑risk cardiovascular patients: reduces the risk of stroke and myocardial infarction as part of a comprehensive regimen. - Elderly patients with systolic hypertension: provides effective BP lowering with a favorable tolerability profile.

What are the side effects of Olmesartan Medoxomil, Amlodipine?

Adverse reactions reported with the olmesartan/amlodipine combination are generally dose‑related and may vary in frequency.

Common Side Effects: - Peripheral edema: swelling of the lower limbs. - Dizziness or light‑headedness: especially after the first doses. - Headache: mild to moderate intensity. - Flushing: transient warmth and redness. - Fatigue: general sense of tiredness. - Nausea: occasional stomach upset.

Serious or Rare Side Effects: - Angio‑edema: rapid swelling of face, lips or throat. - Severe hypotension: symptomatic low blood pressure. - Hepatic dysfunction: elevated liver enzymes. - Renal impairment: worsening kidney function. - Cardiac arrhythmias: irregular heart rhythms. - Allergic reactions: rash, pruritus, or anaphylaxis.

What precautions apply to Olmesartan Medoxomil, Amlodipine?

Before initiating therapy, clinicians should evaluate patient history and monitor relevant parameters. - Renal function: assess baseline creatinine and eGFR. - Hepatic function: check liver enzymes in patients with liver disease. - Electrolytes: monitor potassium levels, especially if combined with potassium‑sparing diuretics. - Pregnancy: avoid use; teratogenic risk is associated with ARBs. - Concomitant antihypertensives: adjust dose to prevent excessive hypotension. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

What does Olmesartan Medoxomil, Amlodipine interact with?

Olmesartan/amlodipine may interact with several drug classes, requiring clinical awareness.

Major Interactions (Avoid): - Dual renin‑angiotensin system blockade: combining with ACE inhibitors or other ARBs can increase risk of renal dysfunction and hyperkalaemia. - Potassium‑rich supplements or potassium‑sparing diuretics: may cause dangerous hyperkalaemia. - Strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin): can raise amlodipine plasma levels.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive effect and affect renal function. - Diuretics: may enhance hypotensive response, requiring dose adjustment. - Lithium: concurrent use can increase lithium concentrations. - Antidiabetic agents: blood‑glucose control may improve, risking hypoglycaemia. - Alcohol: additive vasodilatory effect may increase dizziness.

Frequently asked questions

What is Olmesartán/Amlodipino Stada used for?+
Olmesartán/Amlodipino Stada is a fixed‑dose combination of olmesartan medoxil and amlodipine used to treat high blood pressure, especially when a single agent does not achieve target levels. It is prescribed for adults with essential hypertension and may be part of a broader cardiovascular risk‑reduction strategy.
How does olmesartan medoxil work in this product?+
Olmesartan medoxil blocks AT1 angiotensin II receptors, preventing vasoconstriction and aldosterone‑mediated sodium retention. This action lowers systemic vascular resistance and blood pressure. When combined with amlodipine, which relaxes arterial smooth muscle by inhibiting calcium influx, the two agents provide complementary blood‑pressure reduction.
What is the usual dose of Olmesartán/Amlodipino Stada?+
The appropriate dose is determined by the prescribing clinician based on the patient’s blood‑pressure readings, comorbidities, and response to therapy. Dosage adjustments are made individually; patients should follow the prescriber’s instructions and not alter the regimen without medical advice.
Is Olmesartán/Amlodipino Stada safe during pregnancy or breastfeeding?+
Olmesartan, an ARB, is contraindicated in pregnancy because of potential fetal toxicity, including renal dysfunction and skull hypoplasia. Breastfeeding is not recommended as the drug may pass into milk. Women who are pregnant, planning pregnancy, or nursing should discuss alternative antihypertensive options with their healthcare provider.
How do I order Olmesartán/Amlodipino Stada from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.
How does this combination compare with other antihypertensive options?+
Compared with monotherapy, the olmesartan‑amlodipine combo offers additive blood‑pressure reduction, often achieving targets with fewer tablets. It may be preferred over separate prescriptions for convenience and adherence. Relative to other ARB‑calcium‑channel combinations, efficacy and tolerability are similar, though individual patient response can vary.
What are the recommended storage conditions for Olmesartán/Amlodipino Stada?+
Store the tablets at temperatures below 25 °C in their original packaging. Protect them from moisture, excessive heat and direct sunlight to maintain potency throughout the shelf‑life.
How is Olmesartán/Amlodipino Stada administered?+
The product is taken orally, usually once daily, with or without food. Patients should swallow the tablet whole with a glass of water and follow the dosing schedule prescribed by their clinician.
What are the most serious risks associated with this medication?+
Serious adverse events include angio‑edema, severe hypotension, significant renal impairment, and hepatic dysfunction. Patients should seek immediate medical attention if they experience swelling of the face or throat, dizziness, fainting, or signs of liver injury such as jaundice.
Who should not use Olmesartán/Amlodipino Stada?+
Individuals with known hypersensitivity to olmesartan, amlodipine or any tablet excipients should avoid the product. It is also contraindicated in pregnancy, and caution is advised for patients with severe hepatic or renal impairment, or those on interacting medications such as other ARBs, ACE inhibitors or potassium‑sparing diuretics.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Olmesartan Medoxomil, Amlodipine
Route
Oral Use
Manufacturer
Laboratorio Stada, S.L.
Origin
EU

Related products

Albis

Albis

Olmesartan Medoxomil, Amlodipine

Laboratorios Alter, S.A.
EU
Almacor Duo

Almacor Duo

Olmesartan Medoxomil, Amlodipine

Antibiotice Sa
EU
Alsamod

Alsamod

Olmesartan Medoxomil, Amlodipine

Krka, D.D., Novo Mesto
EU
Amelior

Amelior

Olmesartan Medoxomil, Amlodipine

Menarini International Operations Luxembourg S.A.
EU